Effects of polymyxin B-immobilized fiber hemoperfusion on amino acid imbalance in septic encephalopathy

Blood Purification

Volumn 21, Issue 4-5, 2003, Pages 282-286

  Nakamura, Tsukasa ^a   Kawagoe, Yasuhiro ^a   Matsuda, Takaharu ^b   Ebihara, Isao ^c   Koide, Hikaru ^c  

^a Shinmatsudo Central General Hospital   (Japan)

^b Misato Junshin Hospital   (Japan)

^c KOTO HOSPITAL   (Japan)

Author keywords

Aromatic amino acid; Branched chain amino acid; Cytokine; Encephalopathy; Endotoxin; Polymyxin B immobilized fiber

Indexed keywords

AROMATIC AMINO ACID; BRANCHED CHAIN AMINO ACID; ENDOTOXIN; INTERLEUKIN 6; POLYMYXIN B;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BRAIN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEMOPERFUSION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; TREATMENT OUTCOME;

ADULT; AGED; AMINO ACIDS; AMINO ACIDS, AROMATIC; AMINO ACIDS, BRANCHED-CHAIN; BRAIN DISEASES; ENDOTOXINS; FEMALE; HEMOPERFUSION; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMYXIN B; SEPSIS;

EID: 0141680931     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072546     Document Type: Article

References (17)

1. Papadopoulos MC, Davies DC, Moss RF, Tighe D, Bennett ED: Pathophysiology of septic encephalopathy: A review. Crit Care Med 2000;28:3019-3024.
2. Bogdanski R, Blobner M, Hanel F, Kochs E: Septic encephalopathy. Anasthesiol Intensivmed Notfallmed Schmerzther 1999;34:123-130.
3. Basler T, Meier-Hellmann A, Bredle D, Reinhart K: Amino acid imbalance early in septic encephalopathy. Int Care Med 2002;28:293-298.
4. Aoki M, Kodama M, Tani T, Hanasawa K: Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994;167:412-417.
5. Nakamura T, Ushiyama C, Suzuki Y, Shoji H, Shimada N, Koide H: Hemoperfusion with polymyxin B-immobilized fibers for urinary albumin excretion in septic patients with trauma. ASAIO J 2002;48:244-248.
6. Nakamura T, Ushiyama C, Shoji H, Koide H: Effects of hemoperfusion on serum cardiac troponin T concentrations using polymyxin B-immobilized fibers in septic patients undergoing hemodialysis. ASAIO J 2002;48:41-44.
7. Nakamura T, Ushiyama C, Suzuki Y, Shoji H, Osada S, Shimada N, Koide H: Effect of polymyxin B-immobilized fibre on various mediators in patients with hypothermic sepsis. Clin Intensive Care 2002;12:223-228.
8. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
9. Raicevic R, Jovicic A, Dimitrijevic R, Surbatovic M, Mrenovic T: Septic encephalopathy - Prognostic value of the intensity of consciousness disorder to the outcome of sepsis. Vojnosanit Pregl 2001;58:151-156.
10. Mizock BA, Sabelli HC, Dubin A, Javaid JI, Poulos A, Rackow EC: Septic encephalopathy. Evidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy. Arch Intern Med 1990;150:443-449.
11. Sprung CL, Cerra FB, Freund HR, Schein RM, Konstantinides FN, Marcial EH, Pena M: Amino acid alterations and encephalopathy in the sepsis syndrome. Crit Care Med 1991;19:753-757.
12. Young GB, Bolton CF, Austin TW, Archibald YM, Gonder J, Wells GA: The encephalopathy associated with septic illness. Clin Invest Med 1990;13:297-304.
13. Sprung CL, Peduzzi PN, Shatney CH, Schein RM, Wilson MF, Sheagren JN, Hinshaw LB: Impact of encephalopathy on mortality in the sepsis syndrome. Crit Care Med 1990;18:801-806.
14. Freund HR, Ryan JA Jr, Fischer JE: Amino acid derangements in patients with sepsis: Treatment with branched chain amino acid rich infusion. Ann Surg 1978;188:423-429.
15. Vente JP, Von Meyenfeldt MF, Van Eijk HM, Van Berlo CL, Gouma DJ, Van der Linden CJ, Soeters PB: Plasma-amino acid profiles in sepsis and stress. Ann Surg 1989;209:57-62.
16. Nakamura T, Suzuki Y, Shimada N, Ebihara I, Shoji H, Koide H: Hemoperfusion with polymyxin B-immobilized fiber attenuates the increased plasma levels of thrombomodulin and von Willebrand factor from patients with septic shock. Blood Purif 1998;16:179-186.
17. Nakamura T, Ebihara I, Shoji H, Ushiyama C, Suzuki S, Koide H: Treatment with polymyxin B-immobilized fiber reduced platelet activation in septic shock patients: Decrease in plasma levels of soluble P-selectin, platelet factor-4 and β-thromboglobulin. Inflamm Res 1999;48:171-175.